TickerFacts.

Protara Therapeutics, Inc. (TARA) — Operating Cash Flow

Annual figures by period end, from SEC filings.

2015-12-31: -$17.57M2016-12-31: -$23.69M2017-12-31: -$22.35M2018-12-31: -$23.23M2019-12-31: -$5.01M2020-12-31: -$23.41M2021-12-31: -$34.50M2022-12-31: -$26.46M2023-12-31: -$37.56M2024-12-31: -$35.81M2025-12-31: -$56.37M-$56.37M
2015-12-31Operating Cash Flow (USD)2025-12-31
Period endedOperating Cash FlowChange YoYSource filing
2025-12-31-$56.37M—2026-03-10From 2025-01-01
2024-12-31-$35.81M—2026-03-10From 2024-01-01
2023-12-31-$37.56M—2025-03-05From 2023-01-01
2022-12-31-$26.46M—2024-03-13From 2022-01-01
2021-12-31-$34.50M—2023-03-08From 2021-01-01
2020-12-31-$23.41M—2022-03-09From 2020-01-01
2019-12-31-$5.01M—2021-03-11From 2019-01-01
2018-12-31-$23.23M—2020-03-20From 2018-01-01
2017-12-31-$22.35M—2019-03-13From 2017-01-01
2016-12-31-$23.69M—2019-03-13From 2016-01-01
2015-12-31-$17.57M—2018-03-14From 2015-01-01